An International Publisher for Academic and Scientific Journals
Author Login 
Scholars Journal of Applied Medical Sciences | Volume-8 | Issue-06
Assessment of Parasympathetic Function Test in Breast Cancer Patients after Chemotherapy Treatment by Anthracycline Group of Drug (Doxorubicin)
Ms. Islam Khan, Dr. Raghuveer Choudhary, Dr. Kamla Choudhary, Dr. Garima Jeswani, Dr. Vihan Chawdhary
Published: June 10, 2020 | 165 107
DOI: 10.36347/sjams.2020.v08i06.004
Pages: 1408-1410
Downloads
Abstract
Breast cancer, one of the most common malignancies affecting women worldwide. Treatment of breast cancer by Anthracycline group of drug which are the most effective anticancer treatments ever develops. However, cardio toxicity is a well-recognized side effect of anthracycline treatment and can cause heart failure. The aim of the study was to Assessment of Parasympathetic function test in breast cancer patients after chemotherapy treatment. We enroll 125 symptomatic breast cancer patients (Before and after chemotherapy treatment) who treated with anthracycline group of drug. To assess the Parasympathetic functions CAN Win device was used. The result showed that E/I ratio, Valsalva manoeuvre is highly significantly decreased in breast cancer patients after chemotherapy treatment, but 30:15 Ratio is Non-significantly (NS) decreased in breast cancer patients after chemotherapy treatment.